Renivace and c-reactive protein increased Patient Reports February 13, 2012

Renivace Side Effects Report #4767736-4
Renivace side effect was reported by a Pharmacist from JAPAN on Aug 25, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy  and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, basophil percentage decreased, blood alkaline phosphatase increased, c-reactive protein increased, condition aggravated, dysuria, eosinophil percentage decreased, gamma-glutamyltransferase increased, lymphocyte percentage increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, MAGMITT, PURSENNID, AMLODIN, CLARITIN. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4775021-X
Renivace side effect was reported by a Physician from JAPAN on Sept 02, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy  and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, basophil percentage decreased, blood alkaline phosphatase increased, c-reactive protein increased, dysuria, eosinophil percentage decreased, epilepsy , gamma-glutamyltransferase increased, lymphocyte percentage increased. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, MAGMITT, PURSENNID, AMLODIN, CLARITIN. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4796542-X
Renivace side effect was reported by a Physician from JAPAN on Sept 21, 2005. Female patient, 80 years of age, was diagnosed with hypertension, nocturia, insomnia, epilepsy , gastric ulcer and was treated with Renivace. After drug was administered, patient experienced the following side effects: agranulocytosis, blood alkaline phosphatase increased, c-reactive protein increased, condition aggravated, cystitis, dysuria, epilepsy , gamma-glutamyltransferase increased, nocturia. Renivace dosage: 5 MG QD PO. During the same period patient was treated with TRYPTANOL, MYSLEE, TEGRETOL, GASTER, AMLODIPINE BESYLATE, CLARITIN, MAGMITT, NORVASC. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5200966-6
Renivace side effect was reported by a Physician from JAPAN on Dec 15, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with hypertension, thrombosis prophylaxis, diabetes mellitus non-insulin-dependent, gastric ulcer and was treated with Renivace. After drug was administered, patient experienced the following side effects: acute myocardial infarction, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood immunoglobulin e increased, blood lactate dehydrogenase increased, c-reactive protein increased, interstitial lung disease, lymphocyte stimulation test positive. Renivace dosage: 5 MG QD PO. During the same period patient was treated with BUFFERIN, EUGLUCON, OMEPRAL, PANALDINE, DIOVAN. Patient was hospitalized. Patient recovered.


Renivace Side Effects Report #5451910-8
Renivace side effect was reported by a Physician from JAPAN on Aug 27, 2007. Female patient, 42 years of age, weighting 114.6 lb, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: abasia, c-reactive protein increased, erythema, pain . Renivace dosage: (2.5 MG QD ORAL). During the same period patient was treated with ANPLAG, ASPIRIN, DIART, JUVELA, LIPITOR, NEORAL, PREDONINE. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4890053-9
Renivace side effect was reported by a Physician from JAPAN on Jan 04, 2006. Female patient, 83 years of age, was diagnosed with essential hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: angioneurotic oedema, blood immunoglobulin a increased, blood pressure increased, c-reactive protein increased, complement factor increased. Renivace dosage: 5 MG Q DAY PO. During the same period patient was treated with CEROCRAL, SELBEX, VOLTAREN. Patient recovered.

Renivace Side Effects Report #5500154-X
Renivace side effect was reported by a Physician from JAPAN on Oct 12, 2007. Male patient, 70 years of age, weighting 154.3 lb, was treated with Renivace. After drug was administered, patient experienced the following side effects: c-reactive protein increased, interstitial lung disease, white blood cell count increased. Renivace dosage: (5 MG QD ORAL). During the same period patient was treated with TAKEPRON, CARVEDILOL, LASIX, GRAMALIL, ASPIRIN, TICLOPIDINE, DEPAS, AMLODIPINE. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4751681-4
Renivace side effect was reported by a Pharmacist from JAPAN on Aug 05, 2005. Male patient, 70 years of age, was treated with Renivace. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, c-reactive protein increased, gamma-glutamyltransferase increased, pancytopenia. Renivace dosage: unknown. During the same period patient was treated with GASTER D, PANALDINE, ADALAT, ASPIRIN, CARDENALIN, LAXOBERON, NITOROL, SELOKEN. Patient was hospitalized. Patient recovered.